Literature DB >> 9331269

Tractional force generation by porcine Müller cells: stimulation by growth factors in human vitreous.

C Hardwick1, R Feist, R Morris, M White, D Witherspoon, R Angus, C Guidry.   

Abstract

PURPOSE: To examine the levels of Müller cell contraction-stimulating activity in human vitreous, correlate these levels with clinical presentation, and identify, the causative growth factors.
METHODS: Human vitreous was collected from patients undergoing pars plana vitrectomy (n = 84). Müller cells were isolated from porcine retina and maintained in tissue culture. Tractional forces generated by cells incubated on three-dimensional collagen gels were measured as changes in gel thickness. Contraction-stimulating activity in vitreous (VA) was calculated from the close-response profiles of gel contraction to vitreous protein. The contributions of individual growth factors to vitreous activity (n = 10) were assessed by inhibition with specific neutralizing antibodies.
RESULTS: The mean VA of patients with retinal detachment (3.65) and proliferative vitreoretinopathy stages A, B, and C (2.06) were elevated above that of patients without retinal pathology (vitreous activity = 0.23) or retinal defects alone (0.57). Mean activities in patients with epimacular proliferation (1.22) and vitreous hemorrhage (1.40) were also significantly elevated. The percentage of this activity attributable to insulin-like growth factor 1 (IGF-1) varied from 9.2% to 84.5% with a mean of 61.3%. Similarly, the percent contribution of platelet-derived growth factor (PDGF) ranged from 6.8% to 49.0% with a mean of 26.5%.
CONCLUSIONS: The vitreous of patients with retinal detachment, proliferative retinal disease, and vitreous hemorrhage contain varying amounts of growth factors that stimulate tractional force generation by Müller cells. The majority of the activity can be attributed to IGF-1 and a smaller proportion to PDGF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331269

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

2.  [Vitreal-induced RPE cell traction. Investigation of pathological vitreous samples in an in vitro contraction model].

Authors:  J Beutel; M Lüke; K-U Bartz-Schmidt; S Grisanti
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

3.  Pigment epithelium derived factor as an anti-inflammatory factor against decrease of glutamine synthetase expression in retinal Müller cells under high glucose conditions.

Authors:  Xi Shen; Yisheng Zhong; Bing Xie; Yu Cheng; Qin Jiao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

4.  Isolation and characterization of vitreous insulin-like growth factor binding proteins.

Authors:  Clyde Guidry; Jeffery L King
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

5.  Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.

Authors:  Takeshi Kita; Yasuaki Hata; Ryoichi Arita; Shuhei Kawahara; Muneki Miura; Shintaro Nakao; Yasutaka Mochizuki; Hiroshi Enaida; Yoshinobu Goto; Hiroaki Shimokawa; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

6.  Downregulation of lentivirus-mediated ILK RNAi on tractional force generation in human retinal Müller cells.

Authors:  Yu-ping Zheng; Hui Liu; Hao Zeng; Lei Xiong; Zhao-hui Feng; Nai-xue Sun
Journal:  Acta Pharmacol Sin       Date:  2009-11-16       Impact factor: 6.150

7.  Myofibroblast and extracellular matrix origins in proliferative vitreoretinopathy.

Authors:  Richard M Feist; Jeffery L King; Robert Morris; C Douglas Witherspoon; Clyde Guidry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-26       Impact factor: 3.117

8.  Cell-mediated contraction of vitreous explants from chicken embryo: possibility of screening for therapeutic agents against proliferative vitreoretinal diseases.

Authors:  Keitaro Oki; Yoshiki Miyata; Arata Shimada; Terumasa Nagase; Yoshiya Katsura; Hiroshi Kosano
Journal:  Mol Vis       Date:  2013-11-23       Impact factor: 2.367

9.  The impact of octreotide in experimental proliferative vitreoretinopathy.

Authors:  Ozge Evren; Burak Turgut; Ulku Celiker; Kadir Ates
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

10.  A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells.

Authors:  Alison Heffer; Victor Wang; Jayanth Sridhar; Steven E Feldon; Richard T Libby; Collynn F Woeller; Ajay E Kuriyan
Journal:  Transl Vis Sci Technol       Date:  2020-06-05       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.